Osteoblastic γ-aminobutyric acid, type B receptors negatively regulate osteoblastogenesis toward disturbance of osteoclastogenesis mediated by receptor activator of nuclear factor κB ligand in mouse bone

Yoshifumi Takahata, Takeshi Takarada, Eiichi Hinoi, Yukari Nakamura, Hiroyuki Fujita, Yukio Yoneda

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The prevailing view is that signaling machineries for the neurotransmitterGABAare also expressed by cells outside the CNS. In cultured murine calvarial osteoblasts, mRNA was constitutively expressed for both subunits 1 and 2 of metabotropic GABA B receptor (GABA BR), along with inhibition by the GABA BR agonist baclofen of cAMP formation, alkaline phosphatase (ALP) activity, and Ca 2+ accumulation. Moreover, baclofen significantly inhibited the transactivation of receptor activator of nuclear factor-κB ligand (RANKL) gene in a manner sensitive to a GABA BR antagonist, in addition to decreasing mRNA expression of bone morphogenetic protein-2 (BMP2), osteocalcin, and osterix. In osteoblastic MC3T3-E1 cells stably transfected with GABA BR1 subunit, significant reductions were seen in ALP activity and Ca 2+ accumulation, as well as mRNA expression of osteocalcin, osteopontin, and osterix. In cultured calvarial osteoblasts from GABA BR1-null mice exhibiting low bone mineral density in tibia and femur, by contrast, both ALP activity and Ca 2+ accumulation were significantly increased together with promoted expression of both mRNA and proteins for BMP2 and osterix. No significant change was seen in the number of multinucleated cells stained for tartrate-resistant acid phosphatase during the culture of osteoclasts prepared from GABA BR1-null mice, whereas a significant increase was seen in the number of tartrate-resistant acid phosphatase-positive multinucleated cells in co-culture of osteoclasts with osteoblasts isolated from GABA BR1-null mice. These results suggest that GABA BR is predominantly expressed by osteoblasts to negatively regulate osteoblastogenesis through down-regulation of BMP2 expression toward disturbance of osteoclastogenesis after down-regulation of RANKL expression in mouse bone.

Original languageEnglish
Pages (from-to)32906-32917
Number of pages12
JournalJournal of Biological Chemistry
Volume286
Issue number38
DOIs
Publication statusPublished - Sep 23 2011
Externally publishedYes

Fingerprint

Aminobutyrates
Osteoblasts
Cytoplasmic and Nuclear Receptors
Osteogenesis
Bone Morphogenetic Protein 2
gamma-Aminobutyric Acid
Bone
GABA-B Receptors
Ligands
Alkaline Phosphatase
Bone and Bones
Messenger RNA
Baclofen
Osteocalcin
Osteoclasts
Acid Phosphatase
Down-Regulation
GABA-B Receptor Antagonists
GABA-B Receptor Agonists
Osteopontin

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Osteoblastic γ-aminobutyric acid, type B receptors negatively regulate osteoblastogenesis toward disturbance of osteoclastogenesis mediated by receptor activator of nuclear factor κB ligand in mouse bone. / Takahata, Yoshifumi; Takarada, Takeshi; Hinoi, Eiichi; Nakamura, Yukari; Fujita, Hiroyuki; Yoneda, Yukio.

In: Journal of Biological Chemistry, Vol. 286, No. 38, 23.09.2011, p. 32906-32917.

Research output: Contribution to journalArticle

@article{a6a835d810144f20922f39f99d8771db,
title = "Osteoblastic γ-aminobutyric acid, type B receptors negatively regulate osteoblastogenesis toward disturbance of osteoclastogenesis mediated by receptor activator of nuclear factor κB ligand in mouse bone",
abstract = "The prevailing view is that signaling machineries for the neurotransmitterGABAare also expressed by cells outside the CNS. In cultured murine calvarial osteoblasts, mRNA was constitutively expressed for both subunits 1 and 2 of metabotropic GABA B receptor (GABA BR), along with inhibition by the GABA BR agonist baclofen of cAMP formation, alkaline phosphatase (ALP) activity, and Ca 2+ accumulation. Moreover, baclofen significantly inhibited the transactivation of receptor activator of nuclear factor-κB ligand (RANKL) gene in a manner sensitive to a GABA BR antagonist, in addition to decreasing mRNA expression of bone morphogenetic protein-2 (BMP2), osteocalcin, and osterix. In osteoblastic MC3T3-E1 cells stably transfected with GABA BR1 subunit, significant reductions were seen in ALP activity and Ca 2+ accumulation, as well as mRNA expression of osteocalcin, osteopontin, and osterix. In cultured calvarial osteoblasts from GABA BR1-null mice exhibiting low bone mineral density in tibia and femur, by contrast, both ALP activity and Ca 2+ accumulation were significantly increased together with promoted expression of both mRNA and proteins for BMP2 and osterix. No significant change was seen in the number of multinucleated cells stained for tartrate-resistant acid phosphatase during the culture of osteoclasts prepared from GABA BR1-null mice, whereas a significant increase was seen in the number of tartrate-resistant acid phosphatase-positive multinucleated cells in co-culture of osteoclasts with osteoblasts isolated from GABA BR1-null mice. These results suggest that GABA BR is predominantly expressed by osteoblasts to negatively regulate osteoblastogenesis through down-regulation of BMP2 expression toward disturbance of osteoclastogenesis after down-regulation of RANKL expression in mouse bone.",
author = "Yoshifumi Takahata and Takeshi Takarada and Eiichi Hinoi and Yukari Nakamura and Hiroyuki Fujita and Yukio Yoneda",
year = "2011",
month = "9",
day = "23",
doi = "10.1074/jbc.M111.253526",
language = "English",
volume = "286",
pages = "32906--32917",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "38",

}

TY - JOUR

T1 - Osteoblastic γ-aminobutyric acid, type B receptors negatively regulate osteoblastogenesis toward disturbance of osteoclastogenesis mediated by receptor activator of nuclear factor κB ligand in mouse bone

AU - Takahata, Yoshifumi

AU - Takarada, Takeshi

AU - Hinoi, Eiichi

AU - Nakamura, Yukari

AU - Fujita, Hiroyuki

AU - Yoneda, Yukio

PY - 2011/9/23

Y1 - 2011/9/23

N2 - The prevailing view is that signaling machineries for the neurotransmitterGABAare also expressed by cells outside the CNS. In cultured murine calvarial osteoblasts, mRNA was constitutively expressed for both subunits 1 and 2 of metabotropic GABA B receptor (GABA BR), along with inhibition by the GABA BR agonist baclofen of cAMP formation, alkaline phosphatase (ALP) activity, and Ca 2+ accumulation. Moreover, baclofen significantly inhibited the transactivation of receptor activator of nuclear factor-κB ligand (RANKL) gene in a manner sensitive to a GABA BR antagonist, in addition to decreasing mRNA expression of bone morphogenetic protein-2 (BMP2), osteocalcin, and osterix. In osteoblastic MC3T3-E1 cells stably transfected with GABA BR1 subunit, significant reductions were seen in ALP activity and Ca 2+ accumulation, as well as mRNA expression of osteocalcin, osteopontin, and osterix. In cultured calvarial osteoblasts from GABA BR1-null mice exhibiting low bone mineral density in tibia and femur, by contrast, both ALP activity and Ca 2+ accumulation were significantly increased together with promoted expression of both mRNA and proteins for BMP2 and osterix. No significant change was seen in the number of multinucleated cells stained for tartrate-resistant acid phosphatase during the culture of osteoclasts prepared from GABA BR1-null mice, whereas a significant increase was seen in the number of tartrate-resistant acid phosphatase-positive multinucleated cells in co-culture of osteoclasts with osteoblasts isolated from GABA BR1-null mice. These results suggest that GABA BR is predominantly expressed by osteoblasts to negatively regulate osteoblastogenesis through down-regulation of BMP2 expression toward disturbance of osteoclastogenesis after down-regulation of RANKL expression in mouse bone.

AB - The prevailing view is that signaling machineries for the neurotransmitterGABAare also expressed by cells outside the CNS. In cultured murine calvarial osteoblasts, mRNA was constitutively expressed for both subunits 1 and 2 of metabotropic GABA B receptor (GABA BR), along with inhibition by the GABA BR agonist baclofen of cAMP formation, alkaline phosphatase (ALP) activity, and Ca 2+ accumulation. Moreover, baclofen significantly inhibited the transactivation of receptor activator of nuclear factor-κB ligand (RANKL) gene in a manner sensitive to a GABA BR antagonist, in addition to decreasing mRNA expression of bone morphogenetic protein-2 (BMP2), osteocalcin, and osterix. In osteoblastic MC3T3-E1 cells stably transfected with GABA BR1 subunit, significant reductions were seen in ALP activity and Ca 2+ accumulation, as well as mRNA expression of osteocalcin, osteopontin, and osterix. In cultured calvarial osteoblasts from GABA BR1-null mice exhibiting low bone mineral density in tibia and femur, by contrast, both ALP activity and Ca 2+ accumulation were significantly increased together with promoted expression of both mRNA and proteins for BMP2 and osterix. No significant change was seen in the number of multinucleated cells stained for tartrate-resistant acid phosphatase during the culture of osteoclasts prepared from GABA BR1-null mice, whereas a significant increase was seen in the number of tartrate-resistant acid phosphatase-positive multinucleated cells in co-culture of osteoclasts with osteoblasts isolated from GABA BR1-null mice. These results suggest that GABA BR is predominantly expressed by osteoblasts to negatively regulate osteoblastogenesis through down-regulation of BMP2 expression toward disturbance of osteoclastogenesis after down-regulation of RANKL expression in mouse bone.

UR - http://www.scopus.com/inward/record.url?scp=80053006714&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053006714&partnerID=8YFLogxK

U2 - 10.1074/jbc.M111.253526

DO - 10.1074/jbc.M111.253526

M3 - Article

VL - 286

SP - 32906

EP - 32917

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 38

ER -